High-level expression of ARID1A predicts a favourable outcome in triple-negative breast cancer patients receiving paclitaxel-based chemotherapy.
about
High-level expression of ARID1A predicts a favourable outcome in triple-negative breast cancer patients receiving paclitaxel-based chemotherapy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
High-level expression of ARID1 ...... paclitaxel-based chemotherapy.
@en
High-level expression of ARID1 ...... paclitaxel-based chemotherapy.
@nl
type
label
High-level expression of ARID1 ...... paclitaxel-based chemotherapy.
@en
High-level expression of ARID1 ...... paclitaxel-based chemotherapy.
@nl
prefLabel
High-level expression of ARID1 ...... paclitaxel-based chemotherapy.
@en
High-level expression of ARID1 ...... paclitaxel-based chemotherapy.
@nl
P2093
P2860
P356
P1476
High-level expression of ARID1 ...... paclitaxel-based chemotherapy
@en
P2093
Chih-Jung Kuo
Hui-Yu Lin
I-Jen Chiu
Ing-Jy Tseng
Yuan-Feng Lin
P2860
P304
P356
10.1111/JCMM.13551
P50
P577
2018-02-01T00:00:00Z